Evidence map›Paper›PMID 20409393›Full record

ArticleEmerging infectious diseases2010

Fluoroquinolone-resistant typhoid, South Africa.

Karen H Keddy, Anthony M Smith, Arvinda Sooka, Husna Ismail, Stephen Oliver

Abstract readCase ReportsLetter
In one paragraph

Article in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).The Cochrane database of systematic reviews · 2011
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Occurrence, Antimicrobial Resistance, and Virulence Profiles ofInternational journal of microbiology · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Extensive Drug-ResistantFrontiers in microbiology · 2021
    Article
  10. Article
  11. Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Typhoidal and non-typhoidal Salmonella infections in Africa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
    Review
  16. The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  17. Review
  18. Review
  19. Article
  20. Typhoid fever.Lancet (London, England) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karen H Keddy
Anthony M Smith
Arvinda Sooka
Husna Ismail
Stephen Oliver

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialAgedAnti-Infective AgentsCiprofloxacinDNA, BacterialFemaleGenes, BacterialHumansMicrobial Sensitivity TestsMutation, MissensePhylogenySalmonella typhiSouth AfricaTyphoid FeverAnti-Infective AgentsCiprofloxacinDNA, Bacterial

Identifiers

PMID20409393
PMCPMC2954527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.